Recent reports implicate gut microbiome dysbiosis in the onset and progression of
Alzheimer's disease (AD), yet studies involving model animals overwhelmingly omit the …

The key role played by host-microbiota interactions on human health, disease onset and
progression, and on host response to treatments has increasingly emerged in the latest …

Gut microbiota has emerged as an important key regulator of health and disease status.
Indeed, gut microbial dysbiosis has been identified in an increasing number of diseases …

The gut microbiota-brain axis is suspected to contribute to the development of Alzheimer's
disease (AD), a neurodegenerative disease characterized by amyloid-β plaque deposition …

The gut microbiota (GM) and its metabolites affect the host nervous system and are involved
in the pathogeneses of various neurological diseases. However, the specific GM alterations …

Alzheimer's disease (AD) is the most common form of dementia. However, the
etiopathogenesis of this devastating disease is not fully understood. Recent studies in …

Gut microbiota is proven to be involved in the development of beta amyloid (Aβ) pathology in
Alzheimer's disease (AD). Since there are difficulties in translating microbiota findings based …

The amyloid cascade hypothesis is widely accepted as an explanation for the
neuropathological changes in Alzheimer's disease (AD). However, the role of amyloid-beta …

Gut microbiota, comprising a vast number of microorganism species with complex
metagenome, are known to be associated with Alzheimer's disease (AD) and amyloid …

Alzheimer's disease (AD) is the most common cause of dementia. Epidemiological studies
show the association between AD and type 2 diabetes (T2DM), although the mechanisms …